The Multiple Myeloma Research Foundation (MMRF) and Sundar Jagannath, MD, Director, Multiple Myeloma Program, The Tisch Cancer Institute, Mount Sinai Health System, teamed up recently to host a free patient education symposium at the Sheraton New York. Dr. Jagannath is a renowned researcher and clinician in the treatment of multiple myeloma, a relatively rare cancer of the bone marrow that results from abnormal growth of plasma cells. The MMRF, based in Norwalk, Connecticut, is the world’s No. 1 private funder of multiple myeloma research. The 200 attendees learned about managing the disease and today’s most promising treatment options from leading Mount Sinai clinicians. Participants included Ajai Chari, MD, Director of Clinical Research, Multiple Myeloma Program; and Hearn Jay Cho, MD, Assistant Professor of Medicine (Hematology and Medical Oncology), and Bethann Scarborough, MD, Assistant Professor of Medicine (Geriatrics and Palliative Medicine), at Icahn School of Medicine at Mount Sinai. Mount Sinai’s Multiple Myeloma Program is the largest of its kind in New York City.
